Press Releases

Aptar Pharma’s Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression

Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. This marks...

Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing

Lonza has further strengthened its extensive mycoplasma detection portfolio with the addition of the Lucettaâ„¢ 2 Luminometer, a single-tube system designed to simplify and accelerate mycoplasma detection in cell cultures. Pharmaceutical, biotechnology and academic researchers can...

Almac Group Announces Almac ONE – A Unified Clinical Trial Supply Solution

Almac Group announces Almac ONE™ – providing the first unified Clinical Trial Supply solution. This solution redefines the Clinical Supply Chain experience, creating a responsive end-to-end process that enhances visibility and accuracy throughout the lifecycle of a clinical study....

Nallian launches the Global Pharma Tracker – Early Adopter Program

Data sharing specialist Nallian announces it will be launching the Global Pharma Tracker - Early Adopter Program at the IATA World Cargo Symposium in Singapore next week. The Global Pharma Tracker is the world's first data...

Szpital Specjalistyczny w Brzozowie, Poland, joins the global hospital network on Clinerion’s Patient Network Explorer platform

Szpital Specjalistyczny w Brzozowie, (the Specialist Hospital in Brzozów), Poland, specializes in oncology, hematology and cardiology. The hospital has 485 beds and electronic hospital records for more than 250,000 patients. Each specialization has its own Primary...

TraceLink Submits an Interoperable Blockchain Network Solution for FDA DSCSA Pilot Project Program

TraceLink Inc., the world’s largest integrated digital supply network providing real-time information sharing for better patient outcomes, announced the submission of its interoperable blockchain network solution for the Food and Drug Administration (FDA) Pilot Project Program under the Drug...

Envigo launches PATHWAY, an optimized safety assessment solution to enable first-in-human clinical trials

Envigo, a leading provider of non-clinical contract research services and research models, announced the launch of PATHWAY – an integrated solution that optimizes non-clinical safety assessment programs to enable first-in-human clinical trials. PATHWAY is designed to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read